Acrux gets go-ahead for Phase III
25 June, 2008 by Dylan Bushell-EmblingApproval to commence Phase III trials of testosterone treatment
Viralytics on track with IV delivery
25 June, 2008 by Dylan Bushell-EmblingSingle intravenous dose of Cavatrak passes safety trial
AOS to face competition
25 June, 2008 by Dylan Bushell-EmblingCompeting product cleared for sale by FDA
Portland's strategy on track
25 June, 2008 by Dylan Bushell-EmblingPortland increases sales and revenue, offers rights issue to raise cash
Apollo's proteins sold to NZ
24 June, 2008 by Kate McDonaldNZ biotech Symansis has bought Apollo Cytokine Research.
Novotech wins CRO of the year
20 June, 2008 by Kate McDonaldSydney's Novotech has won another Frost & Sullivan award
Big deal for Bionomics
20 June, 2008 by Dylan Bushell-EmblingBionomics to license compounds to Merck Serono for MS treatment development
SpermSep in top 20
20 June, 2008 by Dylan Bushell-EmblingNuSep's fertility device among top 20 projects to be funded by ARC
Bone Medical scores in South Korea
20 June, 2008 by Dylan Bushell-EmblingBone Medical licenses osteoporosis product to Hyundai Pharmaceuticals
HalcyGen sets sights on supergenerics
20 June, 2008 by Dylan Bushell-EmblingHalcyGen talks up booming supergenerics market
BIO 2008: WA kids wow biotech - "thanks for sending only two"
19 June, 2008 by Kate McDonaldTwo West Australian high school students place highly in international biotech competition
BIO 2008: Sharks give malaria the finger
19 June, 2008 by Kate McDonaldSharks become lifesavers - rather than lifesaver-eaters - in Victorian technological research
Cytopia targeting protein kinases
18 June, 2008 by Dylan Bushell-EmblingCytopia to showcase data from FMS inhibitor trial
SCS goes green
18 June, 2008 by Dylan Bushell-EmblingStem Cell Sciences to license green florescent protein technology
ImpediMed opens States-side
18 June, 2008 by Dylan Bushell-EmblingImpediMed opens new manufacturing office in San Diego
